These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 1320544

  • 1. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.
    Zietse R, Wenting GJ, Kramer P, Schalekamp MA, Weimar W.
    Clin Sci (Lond); 1992 Jun; 82(6):641-50. PubMed ID: 1320544
    [Abstract] [Full Text] [Related]

  • 2. [Effect of cyclosporin A on renal function in patients with glomerulonephritis].
    Heering P, Schneider A, Grabensee B, Plum J.
    Dtsch Med Wochenschr; 2001 Oct 05; 126(40):1093-8. PubMed ID: 11588659
    [Abstract] [Full Text] [Related]

  • 3. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
    Ruggenenti P, Mosconi L, Vendramin G, Moriggi M, Remuzzi A, Sangalli F, Remuzzi G.
    Am J Kidney Dis; 2000 Mar 05; 35(3):381-91. PubMed ID: 10692263
    [Abstract] [Full Text] [Related]

  • 4. Contrasting response to cyclosporin in refractory nephrotic syndrome.
    Zietse R, Wenting GJ, Kramer P, Mulder P, Schalekamp MA, Weimar W.
    Clin Nephrol; 1989 Jan 05; 31(1):22-5. PubMed ID: 2914407
    [Abstract] [Full Text] [Related]

  • 5. Treatment of the nephrotic syndrome with cyclosporin A.
    Ponticelli C.
    J Autoimmun; 1992 Apr 05; 5 Suppl A():315-24. PubMed ID: 1503627
    [Abstract] [Full Text] [Related]

  • 6. Short-term responsiveness of membranous glomerulopathy to cyclosporine.
    Guasch A, Suranyi M, Newton L, Hall BM, Myers BD.
    Am J Kidney Dis; 1992 Nov 05; 20(5):472-81. PubMed ID: 1442759
    [Abstract] [Full Text] [Related]

  • 7. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
    Bomback AS, Canetta PA, Beck LH, Ayalon R, Radhakrishnan J, Appel GB.
    Am J Nephrol; 2012 Nov 05; 36(1):58-67. PubMed ID: 22722778
    [Abstract] [Full Text] [Related]

  • 8. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H, Sugiyama H, Narita I, Saito T, Yamagata K, Nishio S, Fujimoto S, Mori N, Yuzawa Y, Okuda S, Maruyama S, Sato H, Ueda Y, Makino H, Matsuo S.
    Clin Exp Nephrol; 2015 Jun 05; 19(3):496-505. PubMed ID: 25230687
    [Abstract] [Full Text] [Related]

  • 9. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul 05; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 10. [Indications for cyclosporin in the treatment of idiopathic nephrotic syndrome in adults].
    Zietse R, Weimar W.
    Ned Tijdschr Geneeskd; 1992 Sep 05; 136(36):1749-53. PubMed ID: 1407123
    [No Abstract] [Full Text] [Related]

  • 11. Cyclosporin A in the treatment of patients with nephrotic syndrome.
    Pandeva SM, Tzekov VD, Kumchev EP, Tilkian EE, Nikolov DG, Tzvetkova ZT, Manev EI, Anavi BL, Dimitrakov DJ.
    Folia Med (Plovdiv); 2000 Sep 05; 42(2):38-41. PubMed ID: 11217282
    [Abstract] [Full Text] [Related]

  • 12. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
    Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, D'Amico G.
    Am J Kidney Dis; 1997 Sep 05; 30(3):404-12. PubMed ID: 9292570
    [Abstract] [Full Text] [Related]

  • 13. Cyclosporine in idiopathic nephrotic syndrome.
    Ponticelli C.
    Immunopharmacol Immunotoxicol; 1993 Aug 05; 15(4):479-89. PubMed ID: 8227973
    [Abstract] [Full Text] [Related]

  • 14. Extent and course of glomerular injury in human membranous glomerulopathy.
    Guasch A, Sibley RK, Huie P, Myers BD.
    Am J Physiol; 1992 Dec 05; 263(6 Pt 2):F1034-43. PubMed ID: 1282782
    [Abstract] [Full Text] [Related]

  • 15. Enalapril can treat the proteinuria of membranous glomerulonephritis without detriment to systemic or renal hemodynamics.
    Thomas DM, Hillis AN, Coles GA, Davies M, Williams JD.
    Am J Kidney Dis; 1991 Jul 05; 18(1):38-43. PubMed ID: 1712151
    [Abstract] [Full Text] [Related]

  • 16. Cyclosporin and the glomerular filtration barrier in minimal change disease and membranous glomerulopathy.
    Zietse R, Derkx FH, Schalekamp MA, Weimar W.
    Contrib Nephrol; 1995 Jul 05; 114():6-18. PubMed ID: 7587200
    [No Abstract] [Full Text] [Related]

  • 17. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy.
    Morelli E, Loon N, Meyer T, Peters W, Myers BD.
    Diabetes; 1990 Jan 05; 39(1):76-82. PubMed ID: 1698674
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.